Medicyte GmbH Benefits From Multi-Million Euro EU Grant VascuBone

01-Apr-2010 - Germany

MediCyte has been elected partner in the VascuBone project, in which 15 European partners from industry and academic institutions work on practical, yet individual solutions in bone regenerative medicine. The VascuBone project is supported by a 12 million Euro FP7 grant from the European Union starting in 2010 to 2015.

Initiator and organizer of VascuBone is Prof. Dr. Heike Walles, recently appointed head of the Department for Regenerative Medicine at University of Würzburg. The goal of VascuBone is to develop a 'tool box' for bone regeneration, which fulfils basic requirements and is freely combinable with what is needed in the respective patient's situation. Among others, the tool box will include a variation of biocompatible biomaterials and cell types.

With the company's expertise and proprietary technologies, Medicyte's contribution will be to support in developing and supplying cells and cell factors for the VascuBone toolbox. The 15 project partners include Fraunhofer Institute, Johnson & Johnson Medical and Royal Institute of Technology, Sweden.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances